Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (74)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Sipione, S.
Right arrow Articles by Cattaneo, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sipione, S.
Right arrow Articles by Cattaneo, E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2002, Vol. 11, No. 17 1953-1965
© 2002 Oxford University Press

Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses

Simonetta Sipione1,{dagger}, Dorotea Rigamonti1,{dagger}, Marta Valenza1, Chiara Zuccato1, Luciano Conti1, Joel Pritchard2, Charles Kooperberg3, James M. Olson2 and Elena Cattaneo1,*

1Department of Pharmacological Sciences and Center of Excellence on Neurodegenerative Diseases, University of Milano, Via Balzaretti 9, 20133 Milano, Italy and 2Clinical Research Division and 3Public Health Science Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA

Received March 12, 2002; Accepted June 3, 2002

Gene expression studies conducted with mouse models of Huntington's disease (HD) have revealed profound modifications in gene transcription. However, the complexity of in vivo tissue hampers definition of very early transcriptional modifications and does not allow discrimination between cell-autonomous changes and those resulting from intercellular activity processes. To identify early, cell-autonomous transcriptional changes, we compared gene expression profiles of clonal striata-derived cells expressing different N-terminal 548-amino-acid huntingtin fragments (with 26, 67, 105 or 118 glutamines) under the control of a doxycycline-regulated promoter. In these cells, mutant huntingtin did not form aggregates or cause cell death; therefore, the gene expression profiles report transcriptional changes reflecting early pathogenic events. We found that genes involved in cell signaling, transcription, lipid metabolism and vesicle trafficking were affected, in some cases, within 12 hours of mutant protein induction. Interestingly, this study revealed differential expression of a number of genes involved in cholesterol and fatty acid metabolism, suggesting that these metabolic pathways may play a role in HD pathogenesis.

* To whom correspondence should be addressed. Tel: +39 0250318333/349; Fax: +39 0250318284; Email: elena.cattaneo{at}unimi.it

{dagger} The author wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Neurosci.Home page
M.-O. Kim, P. Chawla, R. P. Overland, E. Xia, G. Sadri-Vakili, and J.-H. J. Cha
Altered Histone Monoubiquitylation Mediated by Mutant Huntingtin Induces Transcriptional Dysregulation
J. Neurosci., April 9, 2008; 28(15): 3947 - 3957.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
R. Harada, C. Vadnais, L. Sansregret, L. Leduy, G. Berube, F. Robert, and A. Nepveu
Genome-wide location analysis and expression studies reveal a role for p110 CUX1 in the activation of DNA replication genes
Nucleic Acids Res., January 17, 2008; 36(1): 189 - 202.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
M. Valenza, J. B. Carroll, V. Leoni, L. N. Bertram, I. Bjorkhem, R. R. Singaraja, S. Di Donato, D. Lutjohann, M. R. Hayden, and E. Cattaneo
Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation
Hum. Mol. Genet., September 15, 2007; 16(18): 2187 - 2198.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
C. Zuccato, N. Belyaev, P. Conforti, L. Ooi, M. Tartari, E. Papadimou, M. MacDonald, E. Fossale, S. Zeitlin, N. Buckley, et al.
Widespread Disruption of Repressor Element-1 Silencing Transcription Factor/Neuron-Restrictive Silencer Factor Occupancy at Its Target Genes in Huntington's Disease
J. Neurosci., June 27, 2007; 27(26): 6972 - 6983.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
G. Sadri-Vakili, B. Bouzou, C. L. Benn, M.-O. Kim, P. Chawla, R. P. Overland, K. E. Glajch, E. Xia, Z. Qiu, S. M. Hersch, et al.
Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models
Hum. Mol. Genet., June 1, 2007; 16(11): 1293 - 1306.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
A. N.T. Strehlow, J. Z. Li, and R. M. Myers
Wild-type huntingtin participates in protein trafficking between the Golgi and the extracellular space
Hum. Mol. Genet., February 15, 2007; 16(4): 391 - 409.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
K. Tagawa, S. Marubuchi, M.-L. Qi, Y. Enokido, T. Tamura, R. Inagaki, M. Murata, I. Kanazawa, E. E. Wanker, and H. Okazawa
The Induction Levels of Heat Shock Protein 70 Differentiate the Vulnerabilities to Mutant Huntingtin among Neuronal Subtypes
J. Neurosci., January 24, 2007; 27(4): 868 - 880.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
E. Rockabrand, N. Slepko, A. Pantalone, V. N. Nukala, A. Kazantsev, J. L. Marsh, P. G. Sullivan, J. S. Steffan, S. L. Sensi, and L. M. Thompson
The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis
Hum. Mol. Genet., January 1, 2007; 16(1): 61 - 77.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
E. Trushina, R. D. Singh, R. B. Dyer, S. Cao, V. H. Shah, R. G. Parton, R. E. Pagano, and C. T. McMurray
Mutant huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo
Hum. Mol. Genet., December 15, 2006; 15(24): 3578 - 3591.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Cornett, L. Smith, M. Friedman, J.-Y. Shin, X.-J. Li, and S.-H. Li
Context-dependent Dysregulation of Transcription by Mutant Huntingtin
J. Biol. Chem., November 24, 2006; 281(47): 36198 - 36204.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M. Arango, S. Holbert, D. Zala, E. Brouillet, J. Pearson, E. Regulier, A. K. Thakur, P. Aebischer, R. Wetzel, N. Deglon, et al.
CA150 expression delays striatal cell death in overexpression and knock-in conditions for mutant huntingtin neurotoxicity.
J. Neurosci., April 26, 2006; 26(17): 4649 - 4659.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
A. Hodges, A. D. Strand, A. K. Aragaki, A. Kuhn, T. Sengstag, G. Hughes, L. A. Elliston, C. Hartog, D. R. Goldstein, D. Thu, et al.
Regional and cellular gene expression changes in human Huntington's disease brain
Hum. Mol. Genet., March 15, 2006; 15(6): 965 - 977.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Biol.Home page
A. Pal, F. Severin, B. Lommer, A. Shevchenko, and M. Zerial
Huntingtin-HAP40 complex is a novel Rab5 effector that regulates early endosome motility and is up-regulated in Huntington's disease.
J. Cell Biol., February 13, 2006; 172(4): 605 - 618.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
B. L. Apostol, K. Illes, J. Pallos, L. Bodai, J. Wu, A. Strand, E. S. Schweitzer, J. M. Olson, A. Kazantsev, J. L. Marsh, et al.
Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1/2 protects against mutant huntingtin-associated toxicity
Hum. Mol. Genet., January 15, 2006; 15(2): 273 - 285.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M. Valenza, D. Rigamonti, D. Goffredo, C. Zuccato, S. Fenu, L. Jamot, A. Strand, A. Tarditi, B. Woodman, M. Racchi, et al.
Dysfunction of the Cholesterol Biosynthetic Pathway in Huntington's Disease
J. Neurosci., October 26, 2005; 25(43): 9932 - 9939.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M.-C. Chiang, Y.-C. Lee, C.-L. Huang, and Y. Chern
cAMP-response Element-binding Protein Contributes to Suppression of the A2A Adenosine Receptor Promoter by Mutant Huntingtin with Expanded Polyglutamine Residues
J. Biol. Chem., April 8, 2005; 280(14): 14331 - 14340.
[Abstract] [Full Text] [PDF]

Home page
 NeuroscientistHome page
S.-H. Li and X.-J. Li
Huntington and its Role in Neuronal Degeneration
Neuroscientist, October 1, 2004; 10(5): 467 - 475.
[Abstract] [PDF]

Home page
 Hum Mol GenetHome page
G. Schilling, A. V. Savonenko, A. Klevytska, J. L. Morton, S. M. Tucker, M. Poirier, A. Gale, N. Chan, V. Gonzales, H. H. Slunt, et al.
Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic mice
Hum. Mol. Genet., August 1, 2004; 13(15): 1599 - 1610.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
J. S. Steffan, N. Agrawal, J. Pallos, E. Rockabrand, L. C. Trotman, N. Slepko, K. Illes, T. Lukacsovich, Y.-Z. Zhu, E. Cattaneo, et al.
SUMO Modification of Huntingtin and Huntington's Disease Pathology
Science, April 2, 2004; 304(5667): 100 - 104.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. Trushina, M. P. Heldebrant, C. M. Perez-Terzic, R. Bortolon, I. V. Kovtun, J. D. Badger II, A. Terzic, A. Estevez, A. J. Windebank, R. B. Dyer, et al.
Microtubule destabilization and nuclear entry are sequential steps leading to toxicity in Huntington's disease
PNAS, October 14, 2003; 100(21): 12171 - 12176.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
P. Giuliano, T. de Cristofaro, A. Affaitati, G. M. Pizzulo, A. Feliciello, C. Criscuolo, G. De Michele, A. Filla, E. V. Avvedimento, and S. Varrone
DNA damage induced by polyglutamine-expanded proteins
Hum. Mol. Genet., September 15, 2003; 12(18): 2301 - 2309.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
S. Gines, I. S. Seong, E. Fossale, E. Ivanova, F. Trettel, J. F. Gusella, V. C. Wheeler, F. Persichetti, and M. E. MacDonald
Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice
Hum. Mol. Genet., March 1, 2003; 12(5): 497 - 508.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
A. D. Strand, J. M. Olson, and C. Kooperberg
Estimating the statistical significance of gene expression changes observed with oligonucleotide arrays
Hum. Mol. Genet., September 15, 2002; 11(19): 2207 - 2221.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
R. Luthi-Carter, S. A. Hanson, A. D. Strand, D. A. Bergstrom, W. Chun, N. L. Peters, A. M. Woods, E. Y. Chan, C. Kooperberg, D. Krainc, et al.
Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain
Hum. Mol. Genet., August 15, 2002; 11(17): 1911 - 1926.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
E. Y.W. Chan, R. Luthi-Carter, A. Strand, S. M. Solano, S. A. Hanson, M. M. DeJohn, C. Kooperberg, K. O. Chase, M. DiFiglia, A. B. Young, et al.
Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease
Hum. Mol. Genet., August 15, 2002; 11(17): 1939 - 1951.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.